Marja Helena Jaattela

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 5 EPO patents. Top assignees: Orphazyme A/s, Orphazyme Aps, Zevra Denmark A/s. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marja Helena Jaattela. Retrieved from https://idiyas.com/inventor/marja-helena-jaattela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 26(Granted Patents)

Company Filing History:

Years Active: 2013-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576076 - USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY (2026-03-17),

2. 11938125 - Use of Hsp70 as a regulator of enzymatic activity (2024-03-26),

3. 11304941 - Use of HSP70 as a regulator of enzymatic activity (2022-04-19),

4. 11045460 - Use of Hsp70 as a regulator of enzymatic activity (2021-06-29),

5. 10543204 - Use of Hsp70 as a regulator of enzymatic activity (2020-01-28),

6. 9884058 - Use of Hsp70 as a regulator of enzymatic activity (2018-02-06),

7. 9289472 - Use of HSP70 as a regulator of enzymatic activity (2016-03-22),

8. 8540985 - Use of Hsp70 as a regulator of enzymatic activity (2013-09-24),

Title: The Innovative Contributions of Marja Helena Jaattela

Introduction

Marja Helena Jaattela is a distinguished inventor based in København Ø, Denmark. She has successfully registered six patents that showcase her significant contributions to the field of enzymatic activity modulation.

Latest Patents

One of her latest patents focuses on the "Use of HSP70 as a Regulator of Enzymatic Activity." This invention highlights a method for modulating the enzymatic activity of an enzyme that interacts with BMP. The method involves administering or inducing Hsp70, or its functional fragments or variants, in a way that promotes interaction between BMP and Hsp70. This innovative approach allows for the effective modulation of enzymatic activity associated with BMP.

Career Highlights

Throughout her career, Marja Helena Jaattela has made significant strides in the biotechnology sector. Notably, she worked with Orphazyme Aps and Orphazyme A/S, contributing her expertise to groundbreaking research and development projects within these companies.

Collaborations

In her professional journey, she has collaborated with notable peers, including Thomas Kirkegaard Jensen, which has further enriched her contributions to the field and reinforced the spirit of collaborative innovation.

Conclusion

Marja Helena Jaattela's inventive work and her commitment to advancing biotechnological research exemplify the dynamic nature of innovation in enzymatic activity modulation. With her numerous patents, she continues to inspire future generations of inventors and scientists.

Profile summary based on public USPTO records.